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ABSTRACT 
Statistically designed experiments were used in developing a low serum medium for the production 
of a diagnostic monoclonal antibody against congenital adrenal hyperplasia using Hybridoma 192. A 
two-level half-fractional factorial design was used for screening six components (Minimum Essential 
Medium Eagle amino acids, 2-mercaptoethanol, ethanolamine, ferric citrate, zinc sulfate and sodium 
selenite). The experimental design was then augmented to central composite design. The basal 
Dulbecco's modified Eagle's medium (containing 4 mM L-glutamine, 1% antibiotic-antimycotic agent) 
supplemented with 0.4% by volume fetal bovine serum, 311.8 mM ferric citrate, 17.3 nM sodium 
selenite and 4.5 mM zinc sulfate (LSD), was found to support the growth of the hybridoma. Specific 
cell growth rate in the LSD (0.033 ± 0.001/h) was slightly lower than in the control medium (i.e., basal 
DMEM supplemented with 2% FBS; 0.0045 ± 0.003/h). Nevertheless, the specific MAb production 
rate for LSD was higher (0.057 ± 0.015 pg/cell · h versus 0.004 ± 0.002 pg/cell · h in LSD and control 
respectively). The antibody produced in the LSD showed high specificity and no cross-reactivity with 
the other structural resemblance's steroid hormones, revealing no structural changes owing to the 
new medium developed. The new medium formulation effectively reduced the medium cost by up to 
64.6%. 
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